Revive Therapeutics Clarifies Completion of Key Nerve Agent Countermeasure Study
TORONTO, July 08, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or…
Spectral Medical Inc. Announces Filing of Base Shelf Prospectus
July 04, 2025 15:10 ET | Source: Spectral Medical Inc. TORONTO, July…
PSYENCE GROUP INC. Announces Offering of up to C$600,000 Non-Brokered Private Placement of Common Shares
June 18, 2025 17:36 ET | Source: Psyence Group Inc. TORONTO, June…
LifeLabs Supports Communities Impacted by Saskatchewan Wildfires with $15,000 Donation
Toronto, ON, June 10, 2025 (GLOBE NEWSWIRE) -- In response to the…
Venus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
TORONTO, June 09, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept”…
Venus Concept Announces Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
$1.15 million upfront with up to an additional $2.3 million of potential…